Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Buy
10,034
+728
+8% +$84K 0.26% 101
2025
Q4
$980K Buy
9,306
+2,350
+34% +$221K 0.21% 114
2025
Q3
$584K Buy
6,956
+677
+11% +$55.8K 0.16% 153
2025
Q2
$497K Sell
6,279
-319
-5% -$25.4K 0.14% 160
2025
Q1
$592K Buy
6,598
+120
+2% +$11.2K 0.18% 128
2024
Q4
$644K Buy
6,478
+59
+0.9% +$6.08K 0.2% 115
2024
Q3
$729K Sell
6,419
-121
-2% -$14.4K 0.22% 110
2024
Q2
$810K Buy
6,540
+44
+0.7% +$5.67K 0.27% 97
2024
Q1
$857K Sell
6,496
-56
-0.9% -$6.9K 0.3% 90
2023
Q4
$714K Sell
6,552
-1,637
-20% -$170K 0.27% 102
2023
Q3
$843K Buy
8,189
+624
+8% +$67.3K 0.33% 90
2023
Q2
$873K Buy
7,565
+70
+0.9% +$7.95K 0.32% 87
2023
Q1
$797K Buy
7,495
+34
+0.5% +$3.67K 0.34% 88
2022
Q4
$828K Buy
7,461
+1,153
+18% +$118K 0.37% 84
2022
Q3
$543K Sell
6,308
-8
-0.1% -$714 0.27% 98
2022
Q2
$576K Sell
6,316
-31
-0.5% -$2.75K 0.27% 96
2022
Q1
$521K Buy
6,347
+294
+5% +$23.2K 0.21% 109
2021
Q4
$464K Buy
+6,053
New +$482K 0.21% 108

Other funds holding MRK

MSH Capital Advisors's MRK Position: Q1 2026 in Review

MSH Capital Advisors increased its Merck (MRK) stake by 7.8% in Q1 2026, buying an estimated $84K and bringing the position to 10,034 shares worth $1.21M. The position accounts for 0.26% of the portfolio, ranked #101.

MSH Capital Advisors first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • MSH Capital Advisors held 10,034 shares of Merck worth $1.21M as of Q1 2026.
  • MSH Capital Advisors bought 728 Merck shares in Q1 2026, an estimated $84K.
  • Merck made up 0.26% of MSH Capital Advisors's portfolio in Q1 2026, its #101 holding.
  • MSH Capital Advisors first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on MSH Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.